[Pentosephosphate cycle metabolites as energy-supplying anti-ischemic agents].
A brief review of the experimental data on the energy-yielding effects of pentose-phosphate cycle metabolites is presented. The cardiotropic effects of NADP, fructose-1,6-diphosphate, fructose-6-phosphate, D-ribose and ribose-5-phosphate were analysed with relation to their influence on viability of the ischemic myocardium.
Gatsura
V V
VV
D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy* / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects*; D005636:Fructosephosphates / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D009249:NADP / Q000378:metabolism / Q000627:therapeutic use; D010427:Pentose Phosphate Pathway / Q000187:drug effects*; D012266:Ribose / Q000378:metabolism / Q000627:therapeutic use; D012267:Ribosemonophosphates / Q000378:metabolism / Q000627:therapeutic use
D005636:Fructosephosphates; D012267:Ribosemonophosphates; C031626:ribose-5-phosphate; D009249:NADP; D012266:Ribose
Metabolity pentozofosfatnogo tsikla kak énergoobespechivaiushchie protivoishemicheskie sredstva.